Search Results
Search for other papers by Vassiliki Kotoula in
Google Scholar
PubMed
Search for other papers by Elias Sozopoulos in
Google Scholar
PubMed
Search for other papers by Helen Litsiou in
Google Scholar
PubMed
Search for other papers by Galinos Fanourakis in
Google Scholar
PubMed
Search for other papers by Triantafyllia Koletsa in
Google Scholar
PubMed
Search for other papers by Gerassimos Voutsinas in
Google Scholar
PubMed
Search for other papers by Sophia Tseleni-Balafouta in
Google Scholar
PubMed
Department of Pathology, Department of Pathology, Laboratory of Environmental Mutagenesis and Carcinogenesis, Department of Medical Oncology, Department of Medicine, Institute of Pathology, Memorial Sloan-Kettering Cancer Center, School of Medicine, Aristotle University of Thessaloniki, University Campus, Thessaloniki 54006, Greece
Search for other papers by Constantine S Mitsiades in
Google Scholar
PubMed
Search for other papers by Axel Wellmann in
Google Scholar
PubMed
Department of Pathology, Department of Pathology, Laboratory of Environmental Mutagenesis and Carcinogenesis, Department of Medical Oncology, Department of Medicine, Institute of Pathology, Memorial Sloan-Kettering Cancer Center, School of Medicine, Aristotle University of Thessaloniki, University Campus, Thessaloniki 54006, Greece
Department of Pathology, Department of Pathology, Laboratory of Environmental Mutagenesis and Carcinogenesis, Department of Medical Oncology, Department of Medicine, Institute of Pathology, Memorial Sloan-Kettering Cancer Center, School of Medicine, Aristotle University of Thessaloniki, University Campus, Thessaloniki 54006, Greece
Search for other papers by Nicholas Mitsiades in
Google Scholar
PubMed
slides were counterstained with hematoxylin. Immunostaining was evaluated with a 20× lens by two expert pathologists (V K and T K) who were blinded to the mutational status of the tumors. A scoring system of negative (<10% positive cells per tumor), faint
Search for other papers by Lamis Yehia in
Google Scholar
PubMed
Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA
Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
Germline High Risk Cancer Focus Group, CASE Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, USA
Search for other papers by Charis Eng in
Google Scholar
PubMed
associated point probabilities of <1, 3 and 10%, respectively. Adapted minimally from American Journal of Human Genetics , vol 88 , Tan MH, Mester J, Peterson C et al ., A clinical scoring system for selection of patients for PTEN mutation testing is
Inserm U1016, CNRS UMR 8104, Institut Cochin, Université Paris Descartes-Université de Paris, Paris, France
Search for other papers by Chiara Villa in
Google Scholar
PubMed
Department of Neurosurgery, Hôpital Universitaire Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France
Search for other papers by Bertrand Baussart in
Google Scholar
PubMed
Department of Endocrinology, Center for Rare Adrenal Diseases, Hôpital Cochin APHP, Paris, France
Search for other papers by Guillaume Assié in
Google Scholar
PubMed
Lyon 1 University, Villeurbanne, France
Inserm U1052, CNRS UMR 5286, Cancer Research Center of Lyon, Lyon, France
Search for other papers by Gerald Raverot in
Google Scholar
PubMed
Search for other papers by Federico Roncaroli in
Google Scholar
PubMed
microscopic features. ENDO5 recognises the need for the multidisciplinary staging of PitNETs and of a prognostically relevant and predictive scoring system. CNS5 emphasises that the involvement of parasellar structures affects the extent of surgical
Search for other papers by Meggie M C M Drissen in
Google Scholar
PubMed
Search for other papers by Janet R Vos in
Google Scholar
PubMed
Search for other papers by Romana T Netea-Maier in
Google Scholar
PubMed
Search for other papers by Martin Gotthardt in
Google Scholar
PubMed
Search for other papers by Nicoline Hoogerbrugge in
Google Scholar
PubMed
C Yang Y Chen JL Rybicki LA Milas K Pederson H Remzi B Orloff MS , 2011 A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands . American Journal
Search for other papers by Marie Mc Ilroy in
Google Scholar
PubMed
Search for other papers by Fergal J Fleming in
Google Scholar
PubMed
Search for other papers by Yvonne Buggy in
Google Scholar
PubMed
Search for other papers by Arnold D K Hill in
Google Scholar
PubMed
Search for other papers by Leonie S Young in
Google Scholar
PubMed
controls were performed using matched IgG controls (DAKO). Immunostained slides were scored using the Allred scoring system ( Harvey et al. 1999 ). Two independent observers without knowledge of prognostic factors scored the slides
Search for other papers by Christian F Singer in
Google Scholar
PubMed
Search for other papers by Gernot Hudelist in
Google Scholar
PubMed
Search for other papers by Wolfgang Lamm in
Google Scholar
PubMed
Search for other papers by Ruth Mueller in
Google Scholar
PubMed
Search for other papers by Klaus Czerwenka in
Google Scholar
PubMed
Search for other papers by Ernst Kubista in
Google Scholar
PubMed
-quantitative scoring system (immunoreactive score) was used to allow for a reproducible evaluation of PDGF-R, EGF-R, IGF-1R, c-Abl and c-Kit in immunohistochemically stained tissue sections ( Remmele & Stegner 1987 ). The immunoreactive score (staining intensity
Search for other papers by Peter M van Koetsveld in
Google Scholar
PubMed
Division of Endocrinology, Department of Pathology, Dipartimento di Scienze Mediche, IRCCS Istituto Auxologico Italiano, Department of Pathology, Department of Internal Medicine, Erasmus Medical Center, Erasmus MC, Dr Molewaterplein 50, 3015 GE Rotterdam, The Netherlands
Division of Endocrinology, Department of Pathology, Dipartimento di Scienze Mediche, IRCCS Istituto Auxologico Italiano, Department of Pathology, Department of Internal Medicine, Erasmus Medical Center, Erasmus MC, Dr Molewaterplein 50, 3015 GE Rotterdam, The Netherlands
Search for other papers by Giovanni Vitale in
Google Scholar
PubMed
Search for other papers by Richard A Feelders in
Google Scholar
PubMed
Search for other papers by Marlijn Waaijers in
Google Scholar
PubMed
Search for other papers by Diana M Sprij-Mooij in
Google Scholar
PubMed
Search for other papers by Ronald R de Krijger in
Google Scholar
PubMed
Search for other papers by Ernst-Jan M Speel in
Google Scholar
PubMed
Search for other papers by Johannes Hofland in
Google Scholar
PubMed
Search for other papers by Steven W J Lamberts in
Google Scholar
PubMed
Search for other papers by Wouter W de Herder in
Google Scholar
PubMed
Search for other papers by Leo J Hofland in
Google Scholar
PubMed
scoring systems for adrenocortical carcinomas . Histopathology 51 239 – 245 . ( doi:10.1111/j.1365-2559.2007.02747.x ). Schmittgen TD Livak KJ 2008 Analyzing real-time PCR data by the comparative C (T) method . Nature Protocols 3 1101
Search for other papers by Cecile N Chougnet in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Search for other papers by Caroline Caramella in
Google Scholar
PubMed
Search for other papers by Jean Lumbroso in
Google Scholar
PubMed
Search for other papers by Isabelle Borget in
Google Scholar
PubMed
Search for other papers by Désirée Déandreis in
Google Scholar
PubMed
Search for other papers by Pierre Duvillard in
Google Scholar
PubMed
Search for other papers by Dominique Elias in
Google Scholar
PubMed
Search for other papers by Thierry de Baere in
Google Scholar
PubMed
Search for other papers by Fritz-Line Vélayoudom-Céphise in
Google Scholar
PubMed
Search for other papers by Joël Guigay in
Google Scholar
PubMed
Search for other papers by Michel Ducreux in
Google Scholar
PubMed
Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
Search for other papers by Eric Baudin in
Google Scholar
PubMed
.1038/sj.bjc.6605618 ). Volante M Brizzi MP Faggiano A La Rosa S Rapa I Ferrero A Mansueto G Righi L Garancini S Capella C 2007 Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring
Search for other papers by Satya Das in
Google Scholar
PubMed
Search for other papers by Liping Du in
Google Scholar
PubMed
Search for other papers by Aimee Schad in
Google Scholar
PubMed
Search for other papers by Shikha Jain in
Google Scholar
PubMed
Search for other papers by Aaron Jessop in
Google Scholar
PubMed
Search for other papers by Chirayu Shah in
Google Scholar
PubMed
Search for other papers by David Eisner in
Google Scholar
PubMed
Search for other papers by Dana Cardin in
Google Scholar
PubMed
Search for other papers by Kristen Ciombor in
Google Scholar
PubMed
Search for other papers by Laura Goff in
Google Scholar
PubMed
Search for other papers by Marques Bradshaw in
Google Scholar
PubMed
Search for other papers by Dominique Delbeke in
Google Scholar
PubMed
Search for other papers by Martin Sandler in
Google Scholar
PubMed
Search for other papers by Jordan Berlin in
Google Scholar
PubMed
characterized as well-differentiated. Data analysis A single investigator from VICC generated a CS for each patient based on the scoring system detailed below. Independent radiologists at VICC measured post-treatment response (complete response, partial
Search for other papers by S G Creemers in
Google Scholar
PubMed
Search for other papers by R A Feelders in
Google Scholar
PubMed
Search for other papers by N Valdes in
Google Scholar
PubMed
Institute of Metabolism and System Research, University of Birmingham, Birmingham, UK
Search for other papers by C L Ronchi in
Google Scholar
PubMed
Search for other papers by M Volante in
Google Scholar
PubMed
Search for other papers by B M van Hemel in
Google Scholar
PubMed
Search for other papers by M Luconi in
Google Scholar
PubMed
Search for other papers by M H T Ettaieb in
Google Scholar
PubMed
Search for other papers by M Mannelli in
Google Scholar
PubMed
Search for other papers by M D Chiara in
Google Scholar
PubMed
Search for other papers by M Fassnacht in
Google Scholar
PubMed
Search for other papers by M Papotti in
Google Scholar
PubMed
Search for other papers by M N Kerstens in
Google Scholar
PubMed
Search for other papers by G Nesi in
Google Scholar
PubMed
Search for other papers by H R Haak in
Google Scholar
PubMed
Search for other papers by F J van Kemenade in
Google Scholar
PubMed
Search for other papers by L J Hofland in
Google Scholar
PubMed
), consisting of nine histopathological criteria, is the most frequently used scoring system to differentiate between benign and malignant adrenocortical tumors ( Weiss et al. 1989 , Aubert et al. 2002 ) and is also recommended in the European clinical